Core Laboratories Inc. CLB R2K
Company Overview
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Why Investors Should Care
Net profit has compounded at 10.7% per year over the last five years.
Trades at a P/E of 18.9, below the sector median of 19.6.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $526.52M (+0.5% YoY); net profit $29.67M.
- Trailing 12 Months Year-on-year growth — revenue -1.4%, earnings -5.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 2.9%, profit CAGR 10.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 2.87% |
| 1 Year: | -1.40% |
Compounded Profit Growth
| 5 Years: | 10.74% |
| 1 Year: | -5.51% |
Stock Price Performance
| 1 Year: | -6.89% |
| 6 Months: | -39.03% |
| 3 Months: | -32.29% |
| 1 Month: | -12.83% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.10 · Neutral
P/E of 18.93 is below the sector median of 19.57 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 10.7% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 41.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Energy).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CLB Core Laboratories Inc. R2K | 11.55 | 18.93 | $532.42M | 0.30% | 11.81% | 11.06% | 2.87% | 10.74% |
| 2 | XOM ExxonMobil Holdings Corporation SPX | 145.09 | 24.43 | $601.39B | 3.01% | 11.12% | 9.87% | -6.69% | -19.72% |
| 3 | CVX Chevron Corporation SPX | 181.76 | 31.61 | $361.99B | 3.80% | - | 6.64% | -1.00% | -2.30% |
| 4 | COP ConocoPhillips SPX | 111.87 | 18.96 | $136.29B | 2.87% | - | 11.28% | -6.89% | -2.19% |
| 5 | WMB The Williams Companies, Inc. SPX | 75.98 | 33.32 | $92.92B | 2.87% | 9.66% | 19.66% | 2.91% | 8.51% |
| 6 | VLO Valero Energy Corporation SPX | 301.43 | 22.03 | $89.50B | 1.79% | 8.12% | 15.85% | -11.40% | -41.16% |
| 7 | MPC Marathon Petroleum Corporation SPX | 303.40 | 19.99 | $88.57B | 1.48% | 12.90% | 27.46% | 6.91% | 14.73% |
| 8 | PSX Phillips 66 SPX | 201.45 | 19.91 | $80.77B | 2.83% | 10.78% | 14.55% | -8.00% | -26.36% |
| 9 | EOG EOG Resources, Inc. SPX | 138.01 | 13.57 | $73.51B | 2.99% | 13.55% | 18.20% | 9.75% | 8.81% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 120.90M | 125.97M | 128.36M | 127.88M | 125.34M | 129.64M | 130.58M | 134.40M | 123.58M | 130.16M | 134.52M | 121.80M |
| Operating Income | 11.65M | 14.64M | 6.48M | 18.91M | 14.67M | 8.57M | 16.01M | 19.80M | 4.42M | 15.29M | 20.93M | 1.89M |
| Net Income | 7.07M | 7.52M | 2.37M | 22.85M | 9.26M | 3.22M | 9.03M | 11.74M | -154.00K | 10.64M | 14.24M | -789.00K |
| Diluted EPS | 0.15 | 0.16 | 0.05 | 0.48 | 0.19 | 0.07 | 0.19 | 0.25 | 0.00 | 0.22 | 0.30 | -0.02 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 470.25M | 489.74M | 509.79M | 523.85M | 526.52M |
| Operating Income | 45.26M | 41.52M | 54.64M | 58.56M | 56.47M |
| Net Income | 19.73M | 19.45M | 36.67M | 31.40M | 29.67M |
| Diluted EPS | 0.42 | 0.42 | 0.77 | 0.66 | 0.63 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | 580.85M | 578.35M | 586.39M | 585.13M | 584.01M |
| Total Equity | 75.57M | 161.00M | 184.26M | 224.81M | 246.57M | 265.99M |
| Cash & Equivalents | - | - | 15.43M | 15.12M | 19.16M | 22.70M |
| Long Term Debt | - | - | 172.39M | 163.13M | 126.11M | 110.25M |
| Current Liabilities | - | - | 103.14M | 88.10M | 102.44M | 106.02M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | 36.58M | 24.96M | 24.79M | 56.39M | 37.03M |
| Investing Cash Flow | -10.22M | -3.86M | -6.65M | -6.39M | -2.23M |
| Financing Cash Flow | -22.46M | -23.38M | -18.45M | -45.96M | -31.25M |
| Capital Expenditure | -13.54M | -10.22M | -10.58M | -11.89M | -11.21M |
| Free Cash Flow | 23.04M | 14.74M | 14.21M | 44.50M | 25.82M |
| Share Buybacks | 8.26M | 3.90M | 2.20M | 5.31M | 12.43M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | 9.6% | 8.5% | 10.7% | 11.2% | 10.7% |
| Net Margin % | 4.2% | 4.0% | 7.2% | 6.0% | 5.6% |
| ROE % | 12.3% | 10.6% | 16.3% | 12.7% | 11.2% |
| ROCE % | - | 8.7% | 11.0% | 12.1% | 11.8% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Ariel Investments, LLC | 28.57% | 13.17M | $149.88M |
| 2 | Blackrock Inc. | 15.64% | 7.21M | $82.03M |
| 3 | Disciplined Growth Investors, Inc. | 10.71% | 4.94M | $56.18M |
| 4 | Earnest Partners LLC | 6.63% | 3.06M | $34.78M |
| 5 | State Street Corporation | 4.47% | 2.06M | $23.45M |
| 6 | CWA Asset Management Group, LLC | 3.78% | 1.74M | $19.81M |
| 7 | Vanguard Capital Management LLC | 3.51% | 1.62M | $18.43M |
| 8 | Dimensional Fund Advisors LP | 2.93% | 1.35M | $15.39M |
| 9 | Vanguard Portfolio Management LLC | 2.72% | 1.25M | $14.28M |
| 10 | Geode Capital Management, LLC | 2.47% | 1.14M | $12.95M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CLB
Core Laboratories (NYSE:CLB) Shares Up 5.6% - Should You Buy? - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPd0RsejVsbER0WUJpQVczR1FsX3ZZYndJbWEwT0pPSHVETThydHJ1MGNMR3p5c254dnZHNGJDQXd4QVJEaFdPdDd0a0kzTmZZWmxVc0ROQXFqdjlrTVpDMkFDQzQ5VElOTm9kOUJNY2ZybWdVelViejAyVlgxSllkc0gxcmxTaE9xMW85Nm…
S&P SmallCap 600 swaps in Gulfport Energy and Mobility Global - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOakh5Y3RpcVlCa1VHRmVZWlNYUUMwZllWVEhiWkdvNGUtTkwzNGhoUm5RSlZIUWh2ZjRDcEhZOFE1Y2pFWnIxek5nUVNTLUJ1NW1reDBOYVFhd3k4MXROS0UtRVRuX0drUFAyWElaTE1BRlNhM3V6VUZjbnFhT09WaUFPZHkwSkdMN1gzQ2…
Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQbHJDZ0Rpa1E1ZkdHTkxVa2QzaV9QLVc0M19TSTJRNlYyQ3VtZV9QNnpVaWwzSUNOczV3Q1pXdVNlNDBCZzg4ZmM5WXl3RmZoMUZkdWFBT2I4TUttZnJCeWcyQVl0VXZhc3M1WThwNmVmNTNIaDl4WXlUUzlCU3VkWURNSV9DcWI1RGhYZk…
Core Laboratories, Excelerate Energy, and Black Stone Minerals Shares Are Falling, What You Need To Know - StockStory
<a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxPZHVjaUVucDg1NVVsMlRrS2V1MkpRcGZiUHkxR1JabUFmbFdaVzhzR0V6TWUtTjF4SXo2N2k4bkd1QW1pdFlqNWpYbDN6dDduRjVjTFFocEh1LVNsWm9Kakx2MGlNcE9DcFkzdUhTNnMxbnNpdG9HbWdRX1Q3Rnlab2x4akdUd0xQa2pmUU…
Top Core Laboratories (CLB) Competitors 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE9uV2gyRjdheTZBQldBa3JVNTJsSWs2Y3QwTGRZQkNVYk9BM1BIdlQ4NWxoZnZ0OV9TQTgtRzVTSHRMT0FERGkzX0JiOGJ5d1Y0NVlyYTN2VGNxVEppMjhNRG1RWDdLOHd1QXJRVlNXSDhDb0RPdXlIa0VuVkY?oc=5" target="_blank">…
Behavioral Patterns of CLB and Institutional Flows - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQV3A1V0x6cUt6QzhBQlU0X3hGSmVnNkxKZW1kSGFDNWNWazlRSWlnbEZnNkhJd3hoZEZVQ01iTVJ6ZkF6cnBVWC1wM0FQeEVHWmJ4dkdHM2R4OFM0R3JzU0Q5Rk1HZmVFQ2JTV0E4eERESmJ2MU53X2JjaU9PVUZOaWE4cmhreDFMcW5QZ1…
CLB — Frequently Asked Questions
What is the current share price of Core Laboratories Inc. (CLB)?
As of 2026-07-14 21:23 PDT, Core Laboratories Inc. (CLB) trades at $11.55 on NYSE. Its 52-week range is $9.72 to $19.64.
What is the market capitalisation of CLB?
Core Laboratories Inc. (CLB) has a market capitalisation of $532.42M on NYSE.
What is the P/E ratio of CLB?
CLB trades at a trailing price-to-earnings (P/E) ratio of 18.93. The industry average P/E is 19.57. Its price-to-book (P/B) ratio is 2.25.
Does CLB pay a dividend?
Core Laboratories Inc. (CLB) currently offers a dividend yield of 0.30%.
What is the return on equity (ROE) of CLB?
CLB has a return on equity (ROE) of 11.06%. Its return on capital employed (ROCE) is 11.81%.
Is CLB a good stock to buy?
This page provides a data-driven analysis of Core Laboratories Inc. (CLB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.